首页 > 最新文献

Therapeutic Advances in Ophthalmology最新文献

英文 中文
Teleguided photocoagulation treatments across continents with a remotely programmed laser for retinal diseases. 用远程编程激光进行跨大洲的远程光凝治疗视网膜疾病。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2025-01-16 eCollection Date: 2025-01-01 DOI: 10.1177/25158414241311078
Andrea Cusumano, Robin Ross, Benedetto Falsini, Marco Lombardo

Diabetic retinopathy and retinal vein occlusion represent two prevalent vision-threatening retinal diseases. Retinal laser therapy still plays an important role in treating these conditions, but its successful administration often requires referral to specialized centers and retina experts. It is, therefore, essential to develop a new treatment methodology that enables patients to benefit from the expertise of specialists from reference centers. For this purpose, we investigated the feasibility of teleguided photocoagulation conducted across continents to determine if different ophthalmologists can consensually devise and safely execute treatment plans remotely. Two patients from Italy (Europe) with diabetic retinopathy and one from Arizona (USA) with central retinal vein occlusion underwent retinal photocoagulation using Navilas® 577s with remote teleguidance from the corresponding continental counterpart. The process included remote planning and execution, supported by an audio connection for real-time communication. Teletreatment success criteria included treatment plan completion, patient tolerance, remote connection stability, and technical quality. All treatments have been successfully performed with accurate spot application and no technical issues. Follow-ups at three weeks confirmed positive outcomes for each patient. Remote teleguided retinal photocoagulation appears feasible, offering a promising tool for global collaborations in retina care and potential benefits to regions with limited access to expert supervision.

糖尿病视网膜病变和视网膜静脉阻塞是两种常见的威胁视力的视网膜疾病。视网膜激光治疗在治疗这些疾病中仍然扮演着重要的角色,但其成功的管理往往需要转诊到专门的中心和视网膜专家。因此,必须开发一种新的治疗方法,使患者能够从参考中心专家的专业知识中受益。为此,我们调查了跨大洲进行远程引导光凝治疗的可行性,以确定不同的眼科医生是否可以在双方同意的情况下制定并安全地远程执行治疗计划。两名来自意大利(欧洲)的糖尿病视网膜病变患者和一名来自亚利桑那州(美国)的视网膜中央静脉闭塞患者使用Navilas®577进行视网膜光凝治疗,并从相应的大陆同行进行远程远程引导。该过程包括远程规划和执行,并通过音频连接进行实时通信。远程治疗成功的标准包括治疗计划完成、患者耐受性、远程连接稳定性和技术质量。所有的处理都成功地进行了准确的现场应用,没有任何技术问题。三周后的随访证实了每位患者的阳性结果。远程遥控视网膜光凝似乎是可行的,为视网膜护理的全球合作提供了一个有希望的工具,并为获得专家监督机会有限的地区提供了潜在的好处。
{"title":"Teleguided photocoagulation treatments across continents with a remotely programmed laser for retinal diseases.","authors":"Andrea Cusumano, Robin Ross, Benedetto Falsini, Marco Lombardo","doi":"10.1177/25158414241311078","DOIUrl":"10.1177/25158414241311078","url":null,"abstract":"<p><p>Diabetic retinopathy and retinal vein occlusion represent two prevalent vision-threatening retinal diseases. Retinal laser therapy still plays an important role in treating these conditions, but its successful administration often requires referral to specialized centers and retina experts. It is, therefore, essential to develop a new treatment methodology that enables patients to benefit from the expertise of specialists from reference centers. For this purpose, we investigated the feasibility of teleguided photocoagulation conducted across continents to determine if different ophthalmologists can consensually devise and safely execute treatment plans remotely. Two patients from Italy (Europe) with diabetic retinopathy and one from Arizona (USA) with central retinal vein occlusion underwent retinal photocoagulation using Navilas<sup>®</sup> 577s with remote teleguidance from the corresponding continental counterpart. The process included remote planning and execution, supported by an audio connection for real-time communication. Teletreatment success criteria included treatment plan completion, patient tolerance, remote connection stability, and technical quality. All treatments have been successfully performed with accurate spot application and no technical issues. Follow-ups at three weeks confirmed positive outcomes for each patient. Remote teleguided retinal photocoagulation appears feasible, offering a promising tool for global collaborations in retina care and potential benefits to regions with limited access to expert supervision.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"17 ","pages":"25158414241311078"},"PeriodicalIF":2.3,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world results of the Zeiss selective laser trabeculoplasty in adult South African primary open-angle glaucoma patients. 蔡司选择性激光小梁成形术治疗南非成人原发性开角型青光眼的实际效果。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-12-10 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241302891
Brian Church, Pierre Wassermann

Background: Selective laser trabeculoplasty (SLT) is an effective long-term option for the treatment of open-angle glaucoma.

Objectives: To investigate the real-world efficacy and safety of SLT with the Zeiss VISULAS green laser in medically treated primary open-angle glaucoma (POAG).

Design: Retrospective, single-center study.

Methods: POAG patients ⩾18 years of age on at least one antiglaucoma medication prior to the procedure, who underwent SLT with the Zeiss VISULAS green laser (Carl Zeiss Meditec, Jena, Germany). Medications were terminated or reinstated at subsequent follow-ups depending on the intraocular pressure (IOP) control. The primary efficacy outcome measures were mean reduction in glaucoma medications and mean reduction in IOP at 3, 6, and 12 months compared to baseline. Safety outcomes were intra- or post-procedural complications.

Results: One hundred fifty-six eyes of 156 patients, aged 66.5 ± 13.2 years, were recruited. The mean number of medications was reduced from 2.3 ± 1.0 at baseline to 0.8 ± 1.1 and 0.8 ± 1.2 at 3- and 6 months, respectively (p < 0.001). Despite the reduction of medications, the mean IOP (mmHg) was reduced from 16.6 ± 3.10 at baseline to 15.4 ± 3.82 at 3 months (n = 156) and 15.1 ± 3.30 at 6 months (n = 140) (p < 0.001). IOP reduction ⩾20% was observed in 28.8% of patients at 3 months and 27.9% of patients at 6 months. In the 12-month follow-up group (n = 22), mean medications and IOP (mmHg) at baseline were 2.3 ± 0.9 and 16.0 ± 2.80, respectively, which decreased to 0.9 ± 1.1 (p < 0.001) and 14.5 ± 1.92 (p = 0.103), respectively. At 3- and 6-month post-procedure, 59.6% of patients and 60% of patients, respectively, were medication-free compared to none at baseline. At 6 months, 69.3% of patients maintained IOP lower than or equal to pre-procedure IOP on fewer medications compared to baseline. No vision-threatening intra- or post-procedure complications were noted.

Conclusion: SLT with the Zeiss VISULAS green laser resulted in a clinically and statistically significant reduction in number of medications needed for IOP control. The procedure had a good safety profile similar to that described in the literature for SLT, with no vision-threatening complications.

背景:选择性激光小梁成形术(SLT)是治疗开角型青光眼的一种有效的长期选择。目的:探讨蔡司VISULAS绿色激光SLT治疗原发性开角型青光眼(POAG)的疗效和安全性。设计:回顾性、单中心研究。方法:在手术前使用至少一种抗青光眼药物的年龄大于或等于18岁的POAG患者,使用蔡司VISULAS绿色激光器(卡尔蔡司Meditec,耶拿,德国)进行SLT。根据眼压(IOP)的控制情况,在随后的随访中终止或恢复药物治疗。主要疗效指标是与基线相比,青光眼药物的平均减少量和IOP在3、6和12个月的平均减少量。安全性结果为术中或术后并发症。结果:156例患者156只眼,年龄66.5±13.2岁。平均用药次数从基线时的2.3±1.0次分别减少到3个月和6个月时的0.8±1.1次和0.8±1.2次(p n = 156)和6个月时的15.1±3.30次(n = 140) (p n = 22),平均用药次数和IOP (mmHg)分别从2.3±0.9和16.0±2.80次减少到0.9±1.1次(p p = 0.103)。在术后3个月和6个月,分别有59.6%的患者和60%的患者无药物治疗,而基线时无药物治疗。在6个月时,与基线相比,使用较少药物的69.3%患者IOP低于或等于术前IOP。手术中或术后未见危及视力的并发症。结论:蔡司VISULAS绿色激光的SLT在临床上和统计学上显著减少了IOP控制所需的药物数量。该手术具有良好的安全性,与文献中描述的SLT相似,没有视力威胁并发症。
{"title":"Real-world results of the Zeiss selective laser trabeculoplasty in adult South African primary open-angle glaucoma patients.","authors":"Brian Church, Pierre Wassermann","doi":"10.1177/25158414241302891","DOIUrl":"10.1177/25158414241302891","url":null,"abstract":"<p><strong>Background: </strong>Selective laser trabeculoplasty (SLT) is an effective long-term option for the treatment of open-angle glaucoma.</p><p><strong>Objectives: </strong>To investigate the real-world efficacy and safety of SLT with the Zeiss VISULAS green laser in medically treated primary open-angle glaucoma (POAG).</p><p><strong>Design: </strong>Retrospective, single-center study.</p><p><strong>Methods: </strong>POAG patients ⩾18 years of age on at least one antiglaucoma medication prior to the procedure, who underwent SLT with the Zeiss VISULAS green laser (Carl Zeiss Meditec, Jena, Germany). Medications were terminated or reinstated at subsequent follow-ups depending on the intraocular pressure (IOP) control. The primary efficacy outcome measures were mean reduction in glaucoma medications and mean reduction in IOP at 3, 6, and 12 months compared to baseline. Safety outcomes were intra- or post-procedural complications.</p><p><strong>Results: </strong>One hundred fifty-six eyes of 156 patients, aged 66.5 ± 13.2 years, were recruited. The mean number of medications was reduced from 2.3 ± 1.0 at baseline to 0.8 ± 1.1 and 0.8 ± 1.2 at 3- and 6 months, respectively (<i>p</i> < 0.001). Despite the reduction of medications, the mean IOP (mmHg) was reduced from 16.6 ± 3.10 at baseline to 15.4 ± 3.82 at 3 months (<i>n</i> = 156) and 15.1 ± 3.30 at 6 months (<i>n</i> = 140) (<i>p</i> < 0.001). IOP reduction ⩾20% was observed in 28.8% of patients at 3 months and 27.9% of patients at 6 months. In the 12-month follow-up group (<i>n</i> = 22), mean medications and IOP (mmHg) at baseline were 2.3 ± 0.9 and 16.0 ± 2.80, respectively, which decreased to 0.9 ± 1.1 (<i>p</i> < 0.001) and 14.5 ± 1.92 (<i>p</i> = 0.103), respectively. At 3- and 6-month post-procedure, 59.6% of patients and 60% of patients, respectively, were medication-free compared to none at baseline. At 6 months, 69.3% of patients maintained IOP lower than or equal to pre-procedure IOP on fewer medications compared to baseline. No vision-threatening intra- or post-procedure complications were noted.</p><p><strong>Conclusion: </strong>SLT with the Zeiss VISULAS green laser resulted in a clinically and statistically significant reduction in number of medications needed for IOP control. The procedure had a good safety profile similar to that described in the literature for SLT, with no vision-threatening complications.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241302891"},"PeriodicalIF":2.3,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The missing pieces: an investigation into the parallels between Charles Bonnet, phantom limb and tinnitus syndromes. 缺失的部分:对查尔斯·邦纳、幻肢和耳鸣综合症之间的相似之处的调查。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241302065
Kwame A Baffour-Awuah, Holly Bridge, Hilary Engward, Robert C MacKinnon, I Betina Ip, Jasleen K Jolly

Charles Bonnet syndrome (CBS) is a condition characterised by visual hallucinations of varying complexity on a background of vision loss. CBS research has gained popularity only in recent decades, despite evidence dating back to 1760. Knowledge of CBS among both the patient and professional populations unfortunately remains poor, and little is known of its underlying pathophysiology. CBS parallels two other better-known conditions that occur as a result of sensory loss: phantom limb syndrome (PLS) (aberrant sensation of the presence of a missing limb) and tinnitus (aberrant sensation of sound). As 'phantom' conditions, CBS, PLS and tinnitus share sensory loss as a precipitating factor, and, as subjective perceptual phenomena, face similar challenges to investigations. Thus far, these conditions have been studied separately from each other. This review aims to bridge the conceptual gap between CBS, PLS and tinnitus and seek common lessons between them. It considers the current knowledge base of CBS and explores the extent to which an understanding of PLS and tinnitus could provide valuable insights into the pathology of CBS (including the roles of cortical reorganisation, emotional and cognitive factors), and towards identifying effective potential management for CBS.

查尔斯邦纳综合征(CBS)是一种以视力丧失为背景,以不同复杂性的视幻觉为特征的疾病。哥伦比亚广播公司的研究直到最近几十年才开始流行,尽管有证据可以追溯到1760年。不幸的是,患者和专业人群对CBS的了解仍然很少,对其潜在的病理生理学知之甚少。CBS与另外两种更为人所知的因感觉丧失而发生的情况相似:幻肢综合征(对缺失肢体的异常感觉)和耳鸣(声音的异常感觉)。作为“幻影”条件,CBS、PLS和耳鸣都有感觉丧失作为诱发因素,并且作为主观感知现象,面临着类似的调查挑战。到目前为止,这些条件都是分开研究的。本综述旨在弥合CBS, PLS和耳鸣之间的概念差距,并寻求它们之间的共同经验教训。它考虑了CBS的现有知识基础,并探讨了对PLS和耳鸣的理解在多大程度上可以为CBS的病理(包括皮质重组、情绪和认知因素的作用)提供有价值的见解,并有助于确定CBS的有效潜在管理。
{"title":"The missing pieces: an investigation into the parallels between Charles Bonnet, phantom limb and tinnitus syndromes.","authors":"Kwame A Baffour-Awuah, Holly Bridge, Hilary Engward, Robert C MacKinnon, I Betina Ip, Jasleen K Jolly","doi":"10.1177/25158414241302065","DOIUrl":"10.1177/25158414241302065","url":null,"abstract":"<p><p>Charles Bonnet syndrome (CBS) is a condition characterised by visual hallucinations of varying complexity on a background of vision loss. CBS research has gained popularity only in recent decades, despite evidence dating back to 1760. Knowledge of CBS among both the patient and professional populations unfortunately remains poor, and little is known of its underlying pathophysiology. CBS parallels two other better-known conditions that occur as a result of sensory loss: phantom limb syndrome (PLS) (aberrant sensation of the presence of a missing limb) and tinnitus (aberrant sensation of sound). As 'phantom' conditions, CBS, PLS and tinnitus share sensory loss as a precipitating factor, and, as subjective perceptual phenomena, face similar challenges to investigations. Thus far, these conditions have been studied separately from each other. This review aims to bridge the conceptual gap between CBS, PLS and tinnitus and seek common lessons between them. It considers the current knowledge base of CBS and explores the extent to which an understanding of PLS and tinnitus could provide valuable insights into the pathology of CBS (including the roles of cortical reorganisation, emotional and cognitive factors), and towards identifying effective potential management for CBS.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241302065"},"PeriodicalIF":2.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facial artificial intelligence in ophthalmology and medicine: fundamental and transformative applications. 面部人工智能在眼科和医学:基础和变革性应用。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241302871
Jeremy Jia Hao Chan, Pak Wing Leung, Helena Kilgour, Panagiotis Dervenis

The integration of artificial intelligence (AI) in healthcare, particularly in the domain of facial processing tasks, has witnessed substantial growth in the 21st century. However, this requires sufficient appraisal for clinicians and researchers to adequately understand nomenclature and key concepts commonly used in this field. This article aims to elucidate the diverse applications of facial processing tasks, such as facial landmark extraction, face detection, face tracking, facial expression recognition and action unit detection, and their relevance to ophthalmology and other medical specialties. The keywords 'ophthalmology', 'facial artificial intelligence', 'facial recognition' and 'periorbital measurements' were used on PubMed and Ovid, between September 2012 and September 2022, to identify and screen for eligible articles. Studies reporting on human patients in ophthalmology, plastic, maxillofacial and cosmetic surgery with ocular lesions whose facial biometrics were processed by AI and written in the English language were included. A total of 291 and 513 articles were identified on PubMed and Ovid respectively. Twenty articles were included for analysis in this literature review after duplicates, inaccessible articles and articles without full manuscripts were excluded. Although fully automated algorithms can share the workload in healthcare systems and relieve strains on manpower, rigorous testing is crucial, followed by the challenges of convincing management bodies that it would work in reality, coupled with the costs of implementing specialised functional hardware and software. While patients have a valid concern that it would reduce physical contact with clinicians, it is important for clinicians not to replace clinical decision-making with AI alone.

人工智能(AI)在医疗保健领域的整合,特别是在面部处理任务领域,在21世纪取得了长足的发展。然而,这需要对临床医生和研究人员进行充分的评估,以充分理解该领域常用的术语和关键概念。本文旨在阐述面部特征提取、面部检测、面部跟踪、面部表情识别和动作单元检测等面部处理任务的多种应用,以及它们与眼科等医学专业的相关性。在2012年9月至2022年9月期间,在PubMed和Ovid上使用关键词“眼科”、“面部人工智能”、“面部识别”和“眶周测量”来识别和筛选符合条件的文章。纳入了关于眼科、整形、颌面外科和整容手术中患有眼部病变的人类患者的研究报告,这些患者的面部生物识别信息由人工智能处理并以英语书写。在PubMed和Ovid上分别鉴定出291篇和513篇文章。在排除了重复、无法获取的文章和没有完整手稿的文章后,本文献综述纳入了20篇文章进行分析。尽管完全自动化的算法可以分担医疗系统的工作量,减轻人力压力,但严格的测试至关重要,其次是要让管理机构相信它在现实中是可行的,再加上实现专业功能硬件和软件的成本。虽然患者有理由担心人工智能会减少与临床医生的身体接触,但重要的是,临床医生不要仅仅用人工智能取代临床决策。
{"title":"Facial artificial intelligence in ophthalmology and medicine: fundamental and transformative applications.","authors":"Jeremy Jia Hao Chan, Pak Wing Leung, Helena Kilgour, Panagiotis Dervenis","doi":"10.1177/25158414241302871","DOIUrl":"10.1177/25158414241302871","url":null,"abstract":"<p><p>The integration of artificial intelligence (AI) in healthcare, particularly in the domain of facial processing tasks, has witnessed substantial growth in the 21st century. However, this requires sufficient appraisal for clinicians and researchers to adequately understand nomenclature and key concepts commonly used in this field. This article aims to elucidate the diverse applications of facial processing tasks, such as facial landmark extraction, face detection, face tracking, facial expression recognition and action unit detection, and their relevance to ophthalmology and other medical specialties. The keywords 'ophthalmology', 'facial artificial intelligence', 'facial recognition' and 'periorbital measurements' were used on PubMed and Ovid, between September 2012 and September 2022, to identify and screen for eligible articles. Studies reporting on human patients in ophthalmology, plastic, maxillofacial and cosmetic surgery with ocular lesions whose facial biometrics were processed by AI and written in the English language were included. A total of 291 and 513 articles were identified on PubMed and Ovid respectively. Twenty articles were included for analysis in this literature review after duplicates, inaccessible articles and articles without full manuscripts were excluded. Although fully automated algorithms can share the workload in healthcare systems and relieve strains on manpower, rigorous testing is crucial, followed by the challenges of convincing management bodies that it would work in reality, coupled with the costs of implementing specialised functional hardware and software. While patients have a valid concern that it would reduce physical contact with clinicians, it is important for clinicians not to replace clinical decision-making with AI alone.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241302871"},"PeriodicalIF":2.3,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11618896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chandelier retroillumination-assisted cataract surgery in two cases of congenital aniridia with severe aniridia-associated keratopathy: case series. 吊灯后照辅助白内障手术治疗先天性无虹膜伴严重无虹膜相关性角膜病变2例。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-11-28 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241302879
Joseph Hu, Chao-Chien Hu

Congenital aniridia is a rare genetic eye disorder often associated with PAX6 gene mutations, leading to complex ocular manifestations, including aniridia-associated keratopathy (AAK) and cataracts. The surgical management of cataracts in these patients is particularly challenging due to severe corneal opacities, which obscure key surgical steps such as capsulorhexis and phacoemulsification. This report presents two cases of congenital aniridia with severe AAK, in which chandelier retroillumination-assisted cataract surgery was employed. This technique, typically used in vitreous surgery, provided enhanced visualization of the lens through posterior segment illumination, facilitating successful cataract extraction and intraocular lens implantation. Both patients showed significant postoperative improvement in visual acuity. These cases demonstrate the feasibility and effectiveness of chandelier retroillumination-assisted cataract surgery in patients with congenital aniridia complicated by severe corneal opacity.

先天性无虹膜是一种罕见的遗传性眼病,通常与PAX6基因突变有关,导致复杂的眼部表现,包括无虹膜相关性角膜病变(AAK)和白内障。由于严重的角膜混浊,这些患者的白内障手术治疗尤其具有挑战性,这使得关键的手术步骤如撕囊和超声乳化手术变得模糊。本文报告了两例先天性无虹膜伴严重AAK的病例,其中采用了吊灯后照辅助白内障手术。该技术通常用于玻璃体手术,通过后段照明增强晶状体的可视性,促进白内障摘除和人工晶状体植入术的成功。两例患者术后视力均有明显改善。这些病例证明了吊灯后照辅助白内障手术治疗先天性无虹膜合并严重角膜混浊的可行性和有效性。
{"title":"Chandelier retroillumination-assisted cataract surgery in two cases of congenital aniridia with severe aniridia-associated keratopathy: case series.","authors":"Joseph Hu, Chao-Chien Hu","doi":"10.1177/25158414241302879","DOIUrl":"https://doi.org/10.1177/25158414241302879","url":null,"abstract":"<p><p>Congenital aniridia is a rare genetic eye disorder often associated with PAX6 gene mutations, leading to complex ocular manifestations, including aniridia-associated keratopathy (AAK) and cataracts. The surgical management of cataracts in these patients is particularly challenging due to severe corneal opacities, which obscure key surgical steps such as capsulorhexis and phacoemulsification. This report presents two cases of congenital aniridia with severe AAK, in which chandelier retroillumination-assisted cataract surgery was employed. This technique, typically used in vitreous surgery, provided enhanced visualization of the lens through posterior segment illumination, facilitating successful cataract extraction and intraocular lens implantation. Both patients showed significant postoperative improvement in visual acuity. These cases demonstrate the feasibility and effectiveness of chandelier retroillumination-assisted cataract surgery in patients with congenital aniridia complicated by severe corneal opacity.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241302879"},"PeriodicalIF":2.3,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of continuous blanket suture for severe recurrent pterygium with symblepharon. 连续毯状缝合治疗重度复发性翼状胬肉合并虹膜睫状体的有效性和安全性。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241294191
Huixiang Ma, Jiahui Shen, Xuhao Chen, Xianfeng Ye, Shuxia Xu, Zongduan Zhang

Background: Managing recurrent pterygium combined with symblepharon presents significant challenges in ophthalmology. Clinicians aim to reconstruct the ocular surface, alleviate eye movement restrictions, and minimize recurrence risks.

Objective: Evaluation of efficacy and safety of continuous blanket sutures (CBS) for fixation of large autologous conjunctival grafts in patients with severe recurrent pterygium with symblepharon.

Methods: Retrospective, observational case series. Thirty-nine patients (40 eyes) were included, all with severe recurrent pterygium with symblepharon. During surgery, CBS was employed to affix large autologous conjunctival grafts to the exposed sclera, aiming to restore the ocular surface to smoothness as much as possible. All patients were followed up for more than one year. Main outcome measures include the rate of recurrence, improvement of eye movement, and intraoperative and postoperative complications.

Results: Nearly all patients exhibited a smooth ocular surface and largely restored physiological structures during the follow-up period. There were no graft loss or contraction cases until the last follow-up, with only three eyes experiencing a pterygium recurrence (recurrence rate 7.5%, 3/40). Preoperative eye movement limitations improved significantly from 2.10 ± 0.71 (range 1-3) to 0.33 ± 0.53 (range 0-2; p < 0.001) post-surgery. Other postoperative complications included varying degrees of corneal scarring and a single instance of conjunctival granulomatous hyperplasia (1 eye, 2.5%).

Conclusion: When addressing severe recurrent pterygium with Symblepharon, using CBS to secure large autologous conjunctival grafts during surgery can achieve favorable postoperative outcomes. This surgical method is safe and feasible and effectively rebuilds a smooth ocular surface, improves the appearance of the ocular surface, and reduces the recurrence rate of pterygium after excision.

背景:治疗复发性翼状胬肉合并眼睑外翻是眼科领域的重大挑战。临床医生的目标是重建眼表、减轻眼球活动限制并将复发风险降至最低:评估连续毯状缝合(CBS)用于固定重度复发性翼状胬肉合并眼睑外翻患者的大型自体结膜移植物的有效性和安全性:方法:回顾性观察病例系列。方法:回顾性观察病例系列。39 名患者(40 只眼)均患有重度复发性翼状胬肉并伴有眼睑外翻。在手术过程中,采用 CBS 将大块自体结膜移植物粘贴到暴露的巩膜上,目的是尽可能恢复眼球表面的光滑。所有患者均接受了一年以上的随访。主要结果指标包括复发率、眼球运动改善情况、术中和术后并发症:结果:在随访期间,几乎所有患者的眼表都很光滑,生理结构也基本恢复。直到最后一次随访,都没有出现移植物脱落或萎缩的情况,只有三只眼睛翼状胬肉复发(复发率为 7.5%,3/40)。术前眼球活动受限明显改善,从 2.10 ± 0.71(范围 1-3)降至 0.33 ± 0.53(范围 0-2;P 结论:术后眼球活动受限明显改善:在处理严重的复发性翼状胬肉与Symblepharon时,在手术中使用CBS固定大块自体结膜移植物可获得良好的术后效果。这种手术方法安全可行,能有效重建光滑的眼表,改善眼表外观,降低翼状胬肉切除后的复发率。
{"title":"The efficacy and safety of continuous blanket suture for severe recurrent pterygium with symblepharon.","authors":"Huixiang Ma, Jiahui Shen, Xuhao Chen, Xianfeng Ye, Shuxia Xu, Zongduan Zhang","doi":"10.1177/25158414241294191","DOIUrl":"https://doi.org/10.1177/25158414241294191","url":null,"abstract":"<p><strong>Background: </strong>Managing recurrent pterygium combined with symblepharon presents significant challenges in ophthalmology. Clinicians aim to reconstruct the ocular surface, alleviate eye movement restrictions, and minimize recurrence risks.</p><p><strong>Objective: </strong>Evaluation of efficacy and safety of continuous blanket sutures (CBS) for fixation of large autologous conjunctival grafts in patients with severe recurrent pterygium with symblepharon.</p><p><strong>Methods: </strong>Retrospective, observational case series. Thirty-nine patients (40 eyes) were included, all with severe recurrent pterygium with symblepharon. During surgery, CBS was employed to affix large autologous conjunctival grafts to the exposed sclera, aiming to restore the ocular surface to smoothness as much as possible. All patients were followed up for more than one year. Main outcome measures include the rate of recurrence, improvement of eye movement, and intraoperative and postoperative complications.</p><p><strong>Results: </strong>Nearly all patients exhibited a smooth ocular surface and largely restored physiological structures during the follow-up period. There were no graft loss or contraction cases until the last follow-up, with only three eyes experiencing a pterygium recurrence (recurrence rate 7.5%, 3/40). Preoperative eye movement limitations improved significantly from 2.10 ± 0.71 (range 1-3) to 0.33 ± 0.53 (range 0-2; <i>p</i> < 0.001) post-surgery. Other postoperative complications included varying degrees of corneal scarring and a single instance of conjunctival granulomatous hyperplasia (1 eye, 2.5%).</p><p><strong>Conclusion: </strong>When addressing severe recurrent pterygium with Symblepharon, using CBS to secure large autologous conjunctival grafts during surgery can achieve favorable postoperative outcomes. This surgical method is safe and feasible and effectively rebuilds a smooth ocular surface, improves the appearance of the ocular surface, and reduces the recurrence rate of pterygium after excision.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241294191"},"PeriodicalIF":2.3,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The experiences of visually impaired military veterans with Charles Bonnet syndrome. 患有查尔斯-邦奈特综合症的视障退伍军人的经历。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241294022
Sonali Dave, Lee Jones, Matthew Lee, Lara Ditzel-Finn, Claire Castle, Nikki Heinze, Judith Potts, Mariya Moosajee, Renata S M Gomes

Background: Charles Bonnet syndrome (CBS) refers to the experience of visual hallucinations occurring secondary to sight loss. Although there is an increasing amount of research on this phenomenon, CBS remains a lesser-known outcome of visual impairment, with limited research into the impact on the patient.

Objectives: To explore the experiences and opinions of visually impaired military veterans with CBS regarding the impact of visual hallucinations.

Design: Semi-structured qualitative interviews.

Methods: Forty-six telephone interviews were conducted with members of Blind Veterans UK, a charity for visually impaired ex-service men and women. One-hundred and fifteen individuals at the charity with CBS were identified and invited to a semi-structured interview (participation rate - 40%). Qualitative data was transcribed and analysed using thematic analysis.

Results: Four overarching themes were identified: (1) impact of CBS (2) understanding and management of CBS (3) awareness of CBS (4) recommendations. Negative impact of CBS included feelings of fear, annoyance and disruptions to daily life and quality of life. Negative appraisal of CBS was not necessarily related to negative hallucination content. Participants expressed the value of increased awareness amongst patients and health care professionals. Knowledge and understanding of CBS provided reassurance and was considered an effective strategy to mitigate the negative impact of the condition.

Conclusion: Regardless of hallucination content, CBS has a substantial impact on the lives of people with visual impairment. Increased awareness and information can help to support individuals to manage their CBS more effectively. However, the findings from this study cannot be generalized to people without a military background so further research is required to understand and optimize support for military veterans and civilians with CBS.

背景:查尔斯-波奈综合征(Charles Bonnet syndrome,CBS)是指因视力丧失而产生的视觉幻觉。尽管对这一现象的研究越来越多,但 CBS 仍是一种鲜为人知的视力障碍结果,对患者影响的研究也很有限:目的:探讨患有 CBS 的视力受损退伍军人对视幻觉影响的体验和看法:设计:半结构式定性访谈:对英国盲人退伍军人组织(Blind Veterans UK)的成员进行了 46 次电话访谈,该组织是一个为视力受损的退伍军人服务的慈善机构。该慈善机构确定了 115 名患有 CBS 的个人,并邀请他们参加半结构化访谈(参与率为 40%)。采用主题分析法对定性数据进行转录和分析:结果:确定了四大主题:(1) CBS 的影响 (2) 对 CBS 的理解和管理 (3) 对 CBS 的认识 (4) 建议。CBS 的负面影响包括恐惧感、烦扰感以及对日常生活和生活质量的干扰。对 CBS 的负面评价并不一定与负面幻觉内容有关。参与者表示,提高患者和医护人员对 CBS 的认识很有价值。对 CBS 的了解和认识可让患者安心,并被认为是减轻该病症负面影响的有效策略:无论幻觉内容如何,CBS 都会对视力障碍患者的生活产生重大影响。提高对 CBS 的认识并增加相关信息,有助于帮助他们更有效地管理自己的 CBS。然而,这项研究的结果不能推广到没有军队背景的人身上,因此需要进一步研究,以了解并优化对患有 CBS 的退伍军人和平民的支持。
{"title":"The experiences of visually impaired military veterans with Charles Bonnet syndrome.","authors":"Sonali Dave, Lee Jones, Matthew Lee, Lara Ditzel-Finn, Claire Castle, Nikki Heinze, Judith Potts, Mariya Moosajee, Renata S M Gomes","doi":"10.1177/25158414241294022","DOIUrl":"https://doi.org/10.1177/25158414241294022","url":null,"abstract":"<p><strong>Background: </strong>Charles Bonnet syndrome (CBS) refers to the experience of visual hallucinations occurring secondary to sight loss. Although there is an increasing amount of research on this phenomenon, CBS remains a lesser-known outcome of visual impairment, with limited research into the impact on the patient.</p><p><strong>Objectives: </strong>To explore the experiences and opinions of visually impaired military veterans with CBS regarding the impact of visual hallucinations.</p><p><strong>Design: </strong>Semi-structured qualitative interviews.</p><p><strong>Methods: </strong>Forty-six telephone interviews were conducted with members of Blind Veterans UK, a charity for visually impaired ex-service men and women. One-hundred and fifteen individuals at the charity with CBS were identified and invited to a semi-structured interview (participation rate - 40%). Qualitative data was transcribed and analysed using thematic analysis.</p><p><strong>Results: </strong>Four overarching themes were identified: (1) impact of CBS (2) understanding and management of CBS (3) awareness of CBS (4) recommendations. Negative impact of CBS included feelings of fear, annoyance and disruptions to daily life and quality of life. Negative appraisal of CBS was not necessarily related to negative hallucination content. Participants expressed the value of increased awareness amongst patients and health care professionals. Knowledge and understanding of CBS provided reassurance and was considered an effective strategy to mitigate the negative impact of the condition.</p><p><strong>Conclusion: </strong>Regardless of hallucination content, CBS has a substantial impact on the lives of people with visual impairment. Increased awareness and information can help to support individuals to manage their CBS more effectively. However, the findings from this study cannot be generalized to people without a military background so further research is required to understand and optimize support for military veterans and civilians with CBS.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241294022"},"PeriodicalIF":2.3,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are depression, anxiety and loneliness associated with visual hallucinations in younger adults with Charles Bonnet syndrome? 抑郁、焦虑和孤独与查尔斯-博奈综合征年轻患者的视幻觉有关吗?
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-11-07 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241294177
Robin Walker, Caecilie Valla Broman, Sam Hopkins, Mark Gould, Juliet Holdstock

Background: Charles Bonnet syndrome (CBS) refers to the presence of visual hallucinations experienced by people, without cognitive, or psychiatric deficits that are related to sight loss. This study surveyed younger adults (18-60 years) with visual impairments, to assess the impact of anxiety, depression, loneliness, and the COVID-19 lockdowns on their visual hallucinations.

Objectives: To examine the association between depression, anxiety, loneliness, the COVID-19 lockdowns, and visual hallucinations in younger adults with CBS.

Design: An online survey was used with an opportunistic sample of people with sight loss.

Methods: A survey assessed the frequency, duration, and valence of visual hallucinations using a five-point Likert scale, and assessed anxiety, depression, and loneliness using the Hospital Anxiety and Depression Scale and UCLA (University of California, Los Angeles) loneliness scale, respectively.

Results: Twenty-nine young adults (21 female), aged 22-59 years with vision loss from a range of causes, who experience visual hallucinations, were included in the survey. The majority (76%) of participants had experienced hallucinations within the past week, with 83% stating they occurred frequently or very frequently. For 59% of participants, the hallucinations were of short duration (<2 min), but 34% experienced them continuously. Hallucinations were regarded as being unpleasant by 34% of participants, while 59% rated them as being neutral. The incidence of depression and anxiety was high in the sample (48% and 65%, respectively), and 65% experienced loneliness. Participants with scores indicating anxiety or borderline anxiety had significantly more frequent hallucinations than other participants and a similar trend was found for depression. The COVID-19 lockdowns exacerbated hallucinations in 24% of cases, but for 68% they remained unchanged.

Conclusion: The study demonstrated that CBS is observed in people of all ages, with sight loss arising from a wide range of underlying causes. Depression, anxiety, and loneliness are observed in many cases of CBS. While there was some indication that high anxiety, and to some extent depression, was associated with frequent hallucinations, no other relationships were found between the psychosocial factors (depression, anxiety, and loneliness) and the frequency, duration, or valence of their visual hallucinations.

背景:查尔斯-波奈综合征(CBS)是指视力丧失者在没有认知或精神障碍的情况下出现视幻觉。本研究对有视力障碍的年轻成年人(18-60 岁)进行了调查,以评估焦虑、抑郁、孤独和 COVID-19 闭锁对其视幻觉的影响:研究患有视力障碍的年轻成年人中抑郁、焦虑、孤独、COVID-19锁定与视幻觉之间的关联:设计:对视力丧失者进行在线调查:调查采用李克特五点量表评估视幻觉的频率、持续时间和情感,并分别采用医院焦虑抑郁量表和加州大学洛杉矶分校孤独感量表评估焦虑、抑郁和孤独感:调查对象包括 29 名因各种原因导致视力丧失并出现视幻觉的年轻人(21 名女性),年龄在 22-59 岁之间。大多数参与者(76%)在过去一周内出现过幻觉,其中 83% 表示幻觉经常出现或非常频繁。59%的参与者的幻觉持续时间较短(结论:幻觉是一种常见的精神疾病:研究表明,所有年龄段的人都会出现 CBS,视力丧失的原因多种多样。抑郁、焦虑和孤独是许多 CBS 患者的共同特征。虽然有迹象表明,高度焦虑以及一定程度上的抑郁与频繁出现幻觉有关,但没有发现心理社会因素(抑郁、焦虑和孤独)与视幻觉的频率、持续时间或情绪之间存在其他关系。
{"title":"Are depression, anxiety and loneliness associated with visual hallucinations in younger adults with Charles Bonnet syndrome?","authors":"Robin Walker, Caecilie Valla Broman, Sam Hopkins, Mark Gould, Juliet Holdstock","doi":"10.1177/25158414241294177","DOIUrl":"https://doi.org/10.1177/25158414241294177","url":null,"abstract":"<p><strong>Background: </strong>Charles Bonnet syndrome (CBS) refers to the presence of visual hallucinations experienced by people, without cognitive, or psychiatric deficits that are related to sight loss. This study surveyed younger adults (18-60 years) with visual impairments, to assess the impact of anxiety, depression, loneliness, and the COVID-19 lockdowns on their visual hallucinations.</p><p><strong>Objectives: </strong>To examine the association between depression, anxiety, loneliness, the COVID-19 lockdowns, and visual hallucinations in younger adults with CBS.</p><p><strong>Design: </strong>An online survey was used with an opportunistic sample of people with sight loss.</p><p><strong>Methods: </strong>A survey assessed the frequency, duration, and valence of visual hallucinations using a five-point Likert scale, and assessed anxiety, depression, and loneliness using the Hospital Anxiety and Depression Scale and UCLA (University of California, Los Angeles) loneliness scale, respectively.</p><p><strong>Results: </strong>Twenty-nine young adults (21 female), aged 22-59 years with vision loss from a range of causes, who experience visual hallucinations, were included in the survey. The majority (76%) of participants had experienced hallucinations within the past week, with 83% stating they occurred frequently or very frequently. For 59% of participants, the hallucinations were of short duration (<2 min), but 34% experienced them continuously. Hallucinations were regarded as being unpleasant by 34% of participants, while 59% rated them as being neutral. The incidence of depression and anxiety was high in the sample (48% and 65%, respectively), and 65% experienced loneliness. Participants with scores indicating anxiety or borderline anxiety had significantly more frequent hallucinations than other participants and a similar trend was found for depression. The COVID-19 lockdowns exacerbated hallucinations in 24% of cases, but for 68% they remained unchanged.</p><p><strong>Conclusion: </strong>The study demonstrated that CBS is observed in people of all ages, with sight loss arising from a wide range of underlying causes. Depression, anxiety, and loneliness are observed in many cases of CBS. While there was some indication that high anxiety, and to some extent depression, was associated with frequent hallucinations, no other relationships were found between the psychosocial factors (depression, anxiety, and loneliness) and the frequency, duration, or valence of their visual hallucinations.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241294177"},"PeriodicalIF":2.3,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of allergic conjunctivitis in the Southern region of Saudi Arabia: a cross-sectional study. 沙特阿拉伯南部地区过敏性结膜炎的临床特征:一项横断面研究。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241294020
Waleed ALDhabaan, Saleh Ghulaysi, Albatool Alqahtani, Eman Hurissi, Manar M Alamri, Almuhannad G Alnami, Ahmed H Sumayli, Yahya A Dhamri, Amani A Mosleh, Ethar A Khawaji, Abdullah A Alshahrani, Abdulsalam S Alfaifi, Saja M Alghamdi

Background: Allergic conjunctivitis is a prevalent ocular condition characterized by inflammation of the conjunctiva due to hypersensitivity reactions to various allergens. Understanding its epidemiology and clinical characteristics is crucial for effective management and public health interventions.

Methods: This cross-sectional study investigated the prevalence, triggers, and associated factors of allergic conjunctivitis among residents of the Southern region of Saudi Arabia. Data were collected using a structured questionnaire administered through Google Forms. Statistical analysis was performed using IBM SPSS, including descriptive statistics and bivariable/multivariable analyses.

Results: A total of 693 participants were recruited through convenience sampling via online platforms. Among the participants, 73.9% reported ocular symptoms, while 26.1% did not. Dust emerged as the most common trigger for ocular symptoms (32.9%), followed by eye drops/contact lenses (8.7%), animal dander (6.9%), and chemicals (5.8%). Notably, 39.7% reported experiencing ocular symptoms throughout the year. Despite the prevalence of ocular symptoms, only 26.7% consulted an ophthalmologist. Multivariable analysis revealed that gender and seasonal variation in symptoms were associated with allergic conjunctivitis diagnosis. Females showed a lower odds ratio (OR) of being diagnosed with allergic conjunctivitis compared to males (OR: 0.62, 95% CI: 0.29-1.31), and participants experiencing symptoms with no specific season had significantly lower odds of being diagnosed with allergic conjunctivitis (OR: 0.28, 95% CI: 0.11-0.72). A history of allergic rhinitis demonstrated a strong positive association with allergic conjunctivitis diagnosis (OR: 3.77, 95% CI: 1.83-7.75).

Conclusion: The study highlights the considerable burden of allergic conjunctivitis and the underutilization of healthcare services among affected individuals in the Southern region of Saudi Arabia. Tailored interventions and increased awareness are essential for effective management and mitigation of allergic conjunctivitis's impact on affected individuals and healthcare systems.

背景:过敏性结膜炎是一种常见的眼部疾病,其特点是对各种过敏原的超敏反应导致结膜发炎。了解过敏性结膜炎的流行病学和临床特征对于有效管理和公共卫生干预至关重要:这项横断面研究调查了沙特阿拉伯南部地区居民过敏性结膜炎的发病率、诱发因素和相关因素。通过谷歌表格进行结构化问卷调查,收集数据。统计分析使用 IBM SPSS 进行,包括描述性统计和双变量/多变量分析:通过在线平台的便利抽样,共招募了 693 名参与者。其中,73.9%的参与者报告了眼部症状,26.1%的参与者未报告眼部症状。灰尘是最常见的眼部症状诱因(32.9%),其次是眼药水/隐形眼镜(8.7%)、动物皮屑(6.9%)和化学物质(5.8%)。值得注意的是,39.7%的人表示全年都有眼部症状。尽管眼部症状很普遍,但只有 26.7% 的人咨询过眼科医生。多变量分析显示,性别和症状的季节性变化与过敏性结膜炎的诊断有关。与男性相比,女性被诊断为过敏性结膜炎的几率比(OR)较低(OR:0.62,95% CI:0.29-1.31),而无特定季节症状的参与者被诊断为过敏性结膜炎的几率明显较低(OR:0.28,95% CI:0.11-0.72)。过敏性鼻炎病史与过敏性结膜炎的诊断有很强的正相关性(OR:3.77,95% CI:1.83-7.75):这项研究凸显了沙特阿拉伯南部地区过敏性结膜炎所造成的巨大负担,以及受影响人群对医疗服务利用不足的问题。要有效管理和减轻过敏性结膜炎对患者和医疗系统的影响,就必须采取有针对性的干预措施并提高人们的认识。
{"title":"Clinical characteristics of allergic conjunctivitis in the Southern region of Saudi Arabia: a cross-sectional study.","authors":"Waleed ALDhabaan, Saleh Ghulaysi, Albatool Alqahtani, Eman Hurissi, Manar M Alamri, Almuhannad G Alnami, Ahmed H Sumayli, Yahya A Dhamri, Amani A Mosleh, Ethar A Khawaji, Abdullah A Alshahrani, Abdulsalam S Alfaifi, Saja M Alghamdi","doi":"10.1177/25158414241294020","DOIUrl":"10.1177/25158414241294020","url":null,"abstract":"<p><strong>Background: </strong>Allergic conjunctivitis is a prevalent ocular condition characterized by inflammation of the conjunctiva due to hypersensitivity reactions to various allergens. Understanding its epidemiology and clinical characteristics is crucial for effective management and public health interventions.</p><p><strong>Methods: </strong>This cross-sectional study investigated the prevalence, triggers, and associated factors of allergic conjunctivitis among residents of the Southern region of Saudi Arabia. Data were collected using a structured questionnaire administered through Google Forms. Statistical analysis was performed using IBM SPSS, including descriptive statistics and bivariable/multivariable analyses.</p><p><strong>Results: </strong>A total of 693 participants were recruited through convenience sampling via online platforms. Among the participants, 73.9% reported ocular symptoms, while 26.1% did not. Dust emerged as the most common trigger for ocular symptoms (32.9%), followed by eye drops/contact lenses (8.7%), animal dander (6.9%), and chemicals (5.8%). Notably, 39.7% reported experiencing ocular symptoms throughout the year. Despite the prevalence of ocular symptoms, only 26.7% consulted an ophthalmologist. Multivariable analysis revealed that gender and seasonal variation in symptoms were associated with allergic conjunctivitis diagnosis. Females showed a lower odds ratio (OR) of being diagnosed with allergic conjunctivitis compared to males (OR: 0.62, 95% CI: 0.29-1.31), and participants experiencing symptoms with no specific season had significantly lower odds of being diagnosed with allergic conjunctivitis (OR: 0.28, 95% CI: 0.11-0.72). A history of allergic rhinitis demonstrated a strong positive association with allergic conjunctivitis diagnosis (OR: 3.77, 95% CI: 1.83-7.75).</p><p><strong>Conclusion: </strong>The study highlights the considerable burden of allergic conjunctivitis and the underutilization of healthcare services among affected individuals in the Southern region of Saudi Arabia. Tailored interventions and increased awareness are essential for effective management and mitigation of allergic conjunctivitis's impact on affected individuals and healthcare systems.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241294020"},"PeriodicalIF":2.3,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren. 用光学相干断层血管造影术评估神经性视网膜血管变化。
IF 2.3 Q2 OPHTHALMOLOGY Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.1177/25158414241294024
Melanie Haar, Franz Felix Konen, Marten A Gehlhaar, Irene Oluwatoba-Popoola, Emilia Donicova, Marija Wachsmann, Ahmed Lubbad, Katerina Hufendiek, Amelie Pielen, Bettina Hohberger, Christian Mardin, Stefan Gingele, Nils K Prenzler, Diana Ernst, Torsten Witte, Carsten Framme, Thomas Skripuletz, Tabea Seeliger, Anna Bajor

Background: Sjögren's syndrome is an autoimmune disease characterized by sicca symptoms and various extraglandular manifestations including vasculitis. Neurological involvement occurs frequently (Neuro-Sjögren) and often mimics immune neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP).

Objectives: We aim to assess relevant differences in vessel density (VD) in Optical Coherence Tomography Angiography (OCTA) in those diseases to use it as an easily available diagnostic tool.

Design: Prospective, monocentric pilot-study.

Methods: OCTA (Heidelberg Engineering OCT SPECTRALIS) of the superficial vascular plexus, intermediate capillary plexus (ICP) and deep capillary plexus (DCP) of the retina was prospectively performed in Neuro-Sjögren, age-matched CIDP patients (n = 31, each), and healthy controls (n = 30). Vessel density (VD) and foveal avascular zone (FAZ) was measured with Erlangen Angio Tool.

Results: Significantly lower VD were found for the DCP and ICP in Neuro-Sjögren and CIDP patients compared to healthy controls (p = 0.0002 and <0.0001). When group comparison was age-adjusted, these differences were not found anymore. Different frequencies of "low" retinal blood flow in each layer comparing Neuro-Sjögren and CIDP patients were not found. FAZ revealed no significant differences between patients with Neuro-Sjögren, CIDP and healthy controls.

Conclusion: This study found no significant differences in VD or the foveal avascular zone between Neuro-Sjögren and CIDP patients using OCTA, suggesting that inflammatory vascular changes in the retina are uncommon in Neuro-Sjögren patients.

背景:斯约格伦综合征是一种自身免疫性疾病,以眼症状和包括血管炎在内的各种腺外表现为特征。神经系统经常受累(Neuro-Sjögren),并经常模仿免疫性神经病,如慢性炎症性脱髓鞘性多发性神经病(CIDP):我们旨在评估这些疾病的光学相干断层扫描血管造影术(OCTA)中血管密度(VD)的相关差异,以便将其作为一种简便的诊断工具:设计:前瞻性、单中心试点研究:方法:前瞻性地对神经性视网膜浅层血管丛、中间毛细血管丛(ICP)和深层毛细血管丛(DCP)进行了 OCTA(海德堡工程公司 OCT SPECTRALIS)检查。使用 Erlangen Angio 工具测量了血管密度(VD)和眼窝无血管区(FAZ):结果:与健康对照组相比,神经-Sjögren 和 CIDP 患者的 DCP 和 ICP 的血管密度明显较低(P = 0.0002):本研究利用 OCTA 发现,神经性视网膜病变患者和 CIDP 患者的 VD 或眼窝无血管区没有明显差异,这表明神经性视网膜病变患者的视网膜炎症性血管病变并不常见。
{"title":"Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren.","authors":"Melanie Haar, Franz Felix Konen, Marten A Gehlhaar, Irene Oluwatoba-Popoola, Emilia Donicova, Marija Wachsmann, Ahmed Lubbad, Katerina Hufendiek, Amelie Pielen, Bettina Hohberger, Christian Mardin, Stefan Gingele, Nils K Prenzler, Diana Ernst, Torsten Witte, Carsten Framme, Thomas Skripuletz, Tabea Seeliger, Anna Bajor","doi":"10.1177/25158414241294024","DOIUrl":"10.1177/25158414241294024","url":null,"abstract":"<p><strong>Background: </strong>Sjögren's syndrome is an autoimmune disease characterized by sicca symptoms and various extraglandular manifestations including vasculitis. Neurological involvement occurs frequently (Neuro-Sjögren) and often mimics immune neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP).</p><p><strong>Objectives: </strong>We aim to assess relevant differences in vessel density (VD) in Optical Coherence Tomography Angiography (OCTA) in those diseases to use it as an easily available diagnostic tool.</p><p><strong>Design: </strong>Prospective, monocentric pilot-study.</p><p><strong>Methods: </strong>OCTA (Heidelberg Engineering OCT SPECTRALIS) of the superficial vascular plexus, intermediate capillary plexus (ICP) and deep capillary plexus (DCP) of the retina was prospectively performed in Neuro-Sjögren, age-matched CIDP patients (<i>n</i> = 31, each), and healthy controls (<i>n</i> = 30). Vessel density (VD) and foveal avascular zone (FAZ) was measured with Erlangen Angio Tool.</p><p><strong>Results: </strong>Significantly lower VD were found for the DCP and ICP in Neuro-Sjögren and CIDP patients compared to healthy controls (<i>p</i> = 0.0002 and <0.0001). When group comparison was age-adjusted, these differences were not found anymore. Different frequencies of \"low\" retinal blood flow in each layer comparing Neuro-Sjögren and CIDP patients were not found. FAZ revealed no significant differences between patients with Neuro-Sjögren, CIDP and healthy controls.</p><p><strong>Conclusion: </strong>This study found no significant differences in VD or the foveal avascular zone between Neuro-Sjögren and CIDP patients using OCTA, suggesting that inflammatory vascular changes in the retina are uncommon in Neuro-Sjögren patients.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"16 ","pages":"25158414241294024"},"PeriodicalIF":2.3,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic Advances in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1